Serveur d'exploration Chloroquine - Curation (Istex)

Index « AbsEn.i » - entrée « factor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
facto < factor < factorial  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 175.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000012 (1998) Jan Bondeson [Suède] ; Roger Sundler [Suède]Antimalarial Drugs Inhibit Phospholipase A2 Activation and Induction of Interleukin lβ and Tumor Necrosis Factor α in Macrophages: Implications for Their Mode of Action in Rheumatoid Arthritis
000034 (1988) Robert I. Fox [États-Unis] ; Edward Chan [États-Unis] ; Laurie Benton [États-Unis] ; Sherman Fong [États-Unis] ; Mitchell Friedlaender [États-Unis] ; Francis V. Howell [États-Unis]Treatment of primary Sjögren's syndrome with hydroxychloroquine
000060 (2006) Elizabeth A. Perkett [États-Unis] ; Wojciech Ornatowski [États-Unis] ; Jens F. Poschet [États-Unis] ; Vojo Deretic [États-Unis]Chloroquine normalizes aberrant transforming growth factor beta activity in cystic fibrosis bronchial epithelial cells
000084 (1997) Jan BondesonThe mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines
000093 (2002) Edna Patatanian [États-Unis] ; Dennis F. Thompson [États-Unis]A Review of Methotrexate‐Induced Accelerated Nodulosis
000158 (1985) John M. Young [États-Unis] ; Patrick J. Maloney [États-Unis] ; Shizu N. Jubb [États-Unis] ; Jeffrey S. Clark [États-Unis]Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse
000165 (2003) Xiaohong Zhang [Royaume-Uni] ; Greta J. Sawyer [Royaume-Uni] ; Xuebin Dong [Royaume-Uni] ; Ying Qiu [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni]The in vivo use of chloroquine to promote non‐viral gene delivery to the liver via the portal vein and bile duct
000184 (1997) Uma Kant Misra [États-Unis] ; Govind Gawdi [États-Unis] ; Salvatore V. Pizzo [États-Unis]Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5‐trisphosphate binding to its receptor
000228 (2006) Eugene D. Weinberg [États-Unis]Therapeutic potential of iron chelators in diseases associated with iron mismanagement
000252 (2005) S. Bernatsky ; M. Hudson ; S. Suissa [Canada]Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
000286 (2001) I. Yaffe [Israël]Scanty congenital plasmodium parasites as a possible cause for several autoimmune diseases
000289 (2004) P. Jobanputra [Royaume-Uni] ; J. Wilson [Royaume-Uni] ; K. Douglas [Royaume-Uni] ; A. Burls [Royaume-Uni]A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis
000292 (1996) Jan BondesonEffects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: a review
000295 (2002) K. Pavelka [République tchèque] ; Š. Forejtová [République tchèque] ; A. Pavelková [République tchèque] ; J. Zvárová [République tchèque] ; J. Rovensk [République tchèque] ; A. Tuchy Ová [République tchèque]Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
000310 (2007) L. S Lling Avnon [Israël] ; M. Abu-Shakra [Israël] ; D. Flusser [Israël] ; D. Heimer [Israël] ; N. Sion-Vardy [Israël]Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?
000339 (2008) C. L. Teh [Malaisie] ; J. S. Wong [Malaisie]The pattern and clinical manifestations of rheumatoid arthritis in Sarawak General Hospital
000343 (2001) Y. Xu [États-Unis] ; P H Wiernik [États-Unis]Systemic lupus erythematosus and B-cell hematologic neoplasm
000345 (2012) Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
000396 (2005) I. N. Bruce [Royaume-Uni]‘Not only…but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
000417 (2012) Cheng-Tao Yang [Taïwan] ; Chang-Fu Kuo [Taïwan] ; Shue-Fen Luo [Taïwan] ; Kuang-Hui Yu [Taïwan]Discontinuation of anti-TNF-α therapy in a Chinese cohort of patients with rheumatoid arthritis
000431 (2004) H. Haley ; W. Cantrell ; K. Smith [États-Unis]Infliximab therapy for sarcoidosis (lupus pernio)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "factor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "factor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    factor
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021